Provided by Tiger Fintech (Singapore) Pte. Ltd.

ArTara Therapeutics, Inc.

5.49
-0.2900-5.02%
Post-market: 5.490.00000.00%19:54 EDT
Volume:334.77K
Turnover:1.86M
Market Cap:211.81M
PE:-3.58
High:5.84
Open:5.69
Low:5.44
Close:5.78
52wk High:10.48
52wk Low:1.77
Shares:38.58M
Float Shares:35.46M
Volume Ratio:0.62
T/O Rate:0.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5331
EPS(LYR):-2.1656
ROE:-43.02%
ROA:-27.72%
PB:1.47
PE(LYR):-2.54

Loading ...

LifeSci Capital Reaffirms Their Buy Rating on Protara Therapeutics (TARA)

TIPRANKS
·
Yesterday

Optimistic Outlook for Protara Therapeutics: Buy Rating Driven by Promising TARA-002 Developments and Strategic Opportunities

TIPRANKS
·
Oct 17

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Oct 02

BRIEF-Protara Therapeutics Q2 EPS USD -0.35 Vs. IBES Estimate USD -0.41

Reuters
·
Aug 11

Protara Therapeutics Inc: on Track to Provide Interim Update From Phase 2 Starborn-1 Trial of Tara-002 in Pediatric Lms Patients in 4Q 2025

THOMSON REUTERS
·
Aug 11

Protara Therapeutics Q2 EPS USD -0.35 VS. Ibes Estimate USD -0.41

THOMSON REUTERS
·
Aug 11

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 08

Protara Therapeutics Inc expected to post a loss of 40 cents a share - Earnings Preview

Reuters
·
Aug 01

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Jul 02

Protara Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 13

Protara Therapeutics Inc. Files Initial Beneficial Ownership Statement for William Conkling, Chief Commercial Officer

Reuters
·
Jun 05

BRIEF-Protara Therapeutics Announces Appointment Of William Conkling As Chief Commercial Officer

Reuters
·
Jun 03

Protara Therapeutics Names William Conkling as Chief Commercial Officer

MT Newswires Live
·
Jun 03

Press Release: Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer

Dow Jones
·
Jun 03

Director Richard S. Levy Reports Acquisition of Protara Therapeutics Inc. Common Shares

Reuters
·
May 17

Protara Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

BRIEF-Protara Therapeutics Q1 EPS USD -0.29

Reuters
·
May 08

Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings

Benzinga
·
Apr 28

Protara Therapeutics Price Target Maintained With a $23.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 28